CBIH · Cannabis Bioscience International Holdings, Inc. · Executive Compensation
$0.00
+0.00 (+0.00%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Apr 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As indicated in Note 3 of the notes to the audited consolidated financial statements for the period ended February 28, 2026, and the report thereon of the Company's independent auditing firm, there is substantial doubt as to the ability of the Company to continue as a going concern.”View the 10-Q filed Apr 16, 2026
Market Cap
$2.33M
Shares
11.63B
Volume · Oct 19
568.36M
Avg daily vol (3M)
15.23M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Charles Tamburello | director | Appointed | 2024-11-26 |
| John Jones | treasurer | Appointed | 2024-08-22 |
| John Jones | director | Appointed | 2024-08-22 |
Leadership
- Charles Tamburello Board Member
- John Jones Board Member